胸腺肽、胸腺五肽、胸腺法新之间有啥区别，该如何选择？

参考文献：

1. Mutchnick, M.G., Cummings, G.D.,Hoofnagle, J.H., and D.A. Shafritz (1992) Thymosin: An innovativeapproach to the treatment of chronic hepatitis B, in Combinationtherapies BiologicalResponse Modifiers in the Treatment ofCancer and Infectious Diseases, A.L Goldstein and E. Garaci, Editors. PlenumPublishing Corp: New York. p. 149-156

2. Mutchnick, M.G., Lindsay, K.L.,Schiff, E.R., Cummings, G.D., and H.D. Appelman (1995) Thymosin alpha 1treatment of chronic hepatitis B: a multicenter, randomized, placebo-controlleddouble blind

study Gastroenterology 108(4): p. A1127

3. Lee, S.-D., D.-S. Chen, and Y.-F. Liaw(1997) Multicenter Study of Thymosin Alpha 1 in the Treatment ofChronic Hepatitis B. Data on file.

4. Chien, R.-N., Liaw Y.-F., Chen, T.-C,Yeh, C.-T., and I.-S. Sheen (1998) Efficacy of Thymosin α1 in Patientswith Chronic Hepatitis B: A Randomized, Controlled TrialHepatology 27 (5) May 1998: p.1383-1387.

5. Niedzwiecki, D., Luo, D., Finn, D.S.,Whiting, G.W., Connelly, J.E., Kumashiro, M., Allen, I.E. and S.D. Ross(1997) The efficacy of thymosin alpha 1 in chronic hepatitis B: ameta-analysis, Data on file.

6. Sherman, K.E., Sjogren, M., Greager, R.L.Damiano, M.A., Freeman, S., Lewey, S. Davis, D., Root, S., Weber, F.L., IshakK.G., and Z.D. Goodman (1998) Combination Therapy with Thymosin alpha 1and Interferon for the Treatment of Chronic Hepatitis C Infection: ARandomized, Placebo-Controlled Double-Blind Trial, Hepatology 27 (4):p. 1128-1135

7. Rasi, G., DiVirgilio, D., Mutchnick,M.G., Colella, F, Sinibaldi-Vallebona, P., Pierimarchi, P. Balli, B., and E.Garaci (1996) Combination thymosin α1 and lymphoblastoid interferontreatment in chronic hepatitis C, Gut 39: p. 679-683.

8. Moscarella, S ., Buzzelli, G., MontiM., Giannini, C, Careccia, G. Marrochi, E.M., Romanelli, R.G. and A.L. Zignego(1997) Treatment with interferon-alpha and thymosin alpha 1 of naivepatients affected by chronic hepatitis C, in 4th International meetingon HepatitisC Virus and Related Viruses. Kyoto, Japan

9. Sherman, K.E., and S.N. Sherman(1997) Pooled analysis of interferon + thymosin alpha-1 efficacy forthe treatment of chronic hepatitis C. Second International Conferenceon Therapies for ViralHepatitis, Kona, Big Island Hawaii, December15-19: abstract #P50

10. Stefanini, G.F., et al., Alpha-1 thymosin and transcatheter arterial chemoembolization in hepatocellularcarcinoma patients: a preliminary experienceHepatogastroenterology, 1988. 45 (19): p.209-215

11. Schulof, R.S., et al., A randomizedtrial to evaluate the immunorestorative properties of synthetic thymosin alpha1 in patients with lungcancer. Journal of Biological ResponseModifiers 1985 4: p. 147-158

12. Salvati, F, et al., Combinedtreatment with thymosin alpha 1 and low dose interferon-alpha after ifosfamidein non-smallcell lung cancer: a phase II controlledtrial. Anticancer Research 1996 16: p. 1001-1004

13. Rasi, G., Terzoli, E., lzzo, F., etal., Combined treatment with thymosin alpha 1 and low dose nterferon alphaafter dacarbazine in advanced melanoma. Melanoma Research 2000 10: p 189-192

14. Lopez, M, et al., Biochemotherapywith thymosin alpha 1, inteluken-2 and dacarbazine in patients with metastaticmelanoma: clinical and immunological effects. Annals of Oncology 1994 5: p. 741-746.